List of articles with "Immunotherapy"

Compugen Q3 2025 Update

Compugen Q3 2025 Update

Israel Immunotherapy Compugen Holon CGEN
BioVaxys Debentures Update

BioVaxys Debentures Update

Canada Vancouver Immunotherapy Debentures BioVaxys
ACM-CpG Trials Show Promise

ACM-CpG Trials Show Promise

Singapore Immunotherapy ACM Biolabs ACM-CpG
SCG Unveils HPV Therapy Results

SCG Unveils HPV Therapy Results

Singapore Berlin Immunotherapy HPV cancer SCG142
NK Cell Therapies Lead

NK Cell Therapies Lead

USA San Francisco Immunotherapy GT Biopharma Natural Killer
Invikafusp Alfa's Impact

Invikafusp Alfa's Impact

USA Cambridge Immunotherapy Marengo Therapeutics Invikafusp Alfa
Elephas Live Platform

Elephas Live Platform

India Immunotherapy Bhubaneswar Elephas Biosciences inDNA Life Sciences
BioVaxys LIFE Offering

BioVaxys LIFE Offering

Vancouver Immunotherapy BioVaxys DPX Technology
Immunotherapy Breakthroughs

Immunotherapy Breakthroughs

USA San Francisco Cancer Research Immunotherapy GT Biopharma
CREATE Medicines: A New Era

CREATE Medicines: A New Era

USA Cambridge Immunotherapy RNA Therapy CREATE Medicines
PhotonPharma's New Treatment

PhotonPharma's New Treatment

United States Boston Immunotherapy PhotonPharma Innocell
Dr. Jerome Galon Joins Elephas

Dr. Jerome Galon Joins Elephas

United States Immunotherapy Madison, Wisconsin Dr. Jerome Galon Elephas Biosciences
Marengo at ESMO 2025

Marengo at ESMO 2025

United States Cambridge Immunotherapy Marengo Therapeutics Invikafusp
Growing Liver Cancer Market

Growing Liver Cancer Market

USA Austin AstraZeneca Immunotherapy liver cancer
Hope in Cancer Research

Hope in Cancer Research

USA New York Immunotherapy Oncotelic Therapeutics RNA-based therapies
Cancer Gene Therapy Growth

Cancer Gene Therapy Growth

United States Austin Immunotherapy Gene Editing Cancer Gene Therapy
Cancer Drug Breakthroughs

Cancer Drug Breakthroughs

USA Vancouver oncology Immunotherapy Oncolytics Biotech
Compugen at Genomics 2025

Compugen at Genomics 2025

Israel Immunotherapy Compugen Holon AI/ML
BioVaxys Share Consolidation

BioVaxys Share Consolidation

Canada Vancouver Immunotherapy BioVaxys Share Consolidation
PLPC-DB Immunotherapy

PLPC-DB Immunotherapy

United States Orlando Immunotherapy OGRD Alliance PLPC-DB
Anixa Breast Cancer Vaccine

Anixa Breast Cancer Vaccine

United States Anixa Biosciences San Jose Immunotherapy Breast Cancer Vaccine
Immunotherapy Breakthrough

Immunotherapy Breakthrough

United States Philadelphia Immunotherapy Children's Hospital RNA Fragments
New CTO at Diakonos

New CTO at Diakonos

United States Houston Immunotherapy Diakonos Oncology Donna Rill
Oncolytics Annual Meeting

Oncolytics Annual Meeting

United States San Diego Immunotherapy Oncolytics Biotech pelareorep
Fapon Biopharma Launches Trial

Fapon Biopharma Launches Trial

China Immunotherapy Dongguan Fapon Biopharma FP008
CD40/CD40L Inhibitors Market

CD40/CD40L Inhibitors Market

None Immunotherapy CD40/CD40L Autoimmune Treatments
B7-H4 Therapies Growth

B7-H4 Therapies Growth

None Immunotherapy B7-H4 Therapies B7-H4 Targeting
Oncology Market Surge

Oncology Market Surge

USA Vancouver Immunotherapy Oncolytics Biotech Oncology Market
GlycoNex at BIO Asia-Taiwan

GlycoNex at BIO Asia-Taiwan

Taiwan New Taipei City Immunotherapy GlycoNex BIO Asia-Taiwan
Pelareorep's Effectiveness

Pelareorep's Effectiveness

USA San Diego Immunotherapy Oncolytics Biotech pelareorep
Cancer Innovations Rising

Cancer Innovations Rising

USA Vancouver Cancer Treatment Immunotherapy BioTech Innovations
Pelareorep's Advancements

Pelareorep's Advancements

USA San Diego Immunotherapy Oncolytics Biotech pelareorep
Cervical Cancer Market Growth

Cervical Cancer Market Growth

None Immunotherapy Cervical Cancer HPVs
Nektar Therapeutics Offering

Nektar Therapeutics Offering

United States San Francisco Immunotherapy Nektar Therapeutics NKTR-358
Nektar's $100M Offering

Nektar's $100M Offering

USA San Francisco Immunotherapy Nektar Therapeutics NKTR-358
Nektar's New Offering

Nektar's New Offering

United States biotech San Francisco Immunotherapy Nektar Therapeutics
Autoimmune Disease Treatment

Autoimmune Disease Treatment

USA New York Immunotherapy Autoimmune Diseases Engineered Protein
Cancer Immunotherapy Growth

Cancer Immunotherapy Growth

United States Boston Cancer Treatment oncology Immunotherapy
Vetigenics Starts K9 Study

Vetigenics Starts K9 Study

United States Immunotherapy Madison Vetigenics K9 Study
RyboDyn Joins Lilly Labs

RyboDyn Joins Lilly Labs

USA San Diego Immunotherapy Lilly RyboDyn
Citius Launches LYMPHIR™

Citius Launches LYMPHIR™

United States Cranford Immunotherapy LYMPHIR Citius Oncology
HCB101 Immunotherapy Data

HCB101 Immunotherapy Data

United States Chicago Immunotherapy HanchorBio HCB101
Lotte Invests in Elixiron

Lotte Invests in Elixiron

Japan Immunotherapy Tokyo Lotte Holdings Elixiron
Scinai Gains Italian Clearance

Scinai Gains Italian Clearance

Italy Jerusalem Immunotherapy Scinai Pincell
Adela's Innovative Blood Test

Adela's Innovative Blood Test

United States Immunotherapy cancer detection Foster City, California ADELA
Resistance Mechanisms in Immunotherapy

Resistance Mechanisms in Immunotherapy

Israel Immunotherapy OncoHost Lung Cancer Binyamina
BioVaxys Consolidation Plan

BioVaxys Consolidation Plan

Canada Vancouver Immunotherapy biotechnology BioVaxys Technology
Diakonos Raises $20 Million

Diakonos Raises $20 Million

United States Houston Immunotherapy Glioblastoma Diakonos Oncology
Scinai Q1 2025 Results

Scinai Q1 2025 Results

Israel Jerusalem Immunotherapy Scinai CDMO
BioVaxys & Horizon Deal

BioVaxys & Horizon Deal

Canada Vancouver Immunotherapy BioVaxys Horizon Corp

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.